Global Fibrinogen Concentrates Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Fibrinogen Concentrates market size will reach 1,305.25 Million USD in 2025 and is projected to reach 2,943.70 Million USD by 2032, with a CAGR of 12.32% (2025-2032). Notably, the China Fibrinogen Concentrates market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Fibrinogen concentrates are pharmaceutical products used in medicine to treat individuals with bleeding disorders, particularly those with low levels of fibrinogen in their blood. These concentrates are derived from human plasma or produced using recombinant technology, and they contain concentrated and purified forms of fibrinogen. They are administered intravenously to quickly replenish fibrinogen levels, helping to promote blood clot formation and control bleeding in patients with conditions such as congenital fibrinogen deficiency, acquired hypofibrinogenemia, or as part of massive transfusion protocols in surgical and trauma settings. Fibrinogen concentrates are valuable therapeutic tools in managing bleeding disorders and can be more targeted and efficient than using traditional blood products like fresh frozen plasma.
The major global manufacturers of Fibrinogen Concentrates include CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, GREEN CROSS, Shanghai XinXing Medical, Taibang Biologic, Octapharma, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Fibrinogen Concentrates. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Fibrinogen Concentrates market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Fibrinogen Concentrates market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Fibrinogen Concentrates industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Fibrinogen Concentrates Include:
CSL Behring
LFB Group
Shanghai RAAS Blood Products
Jiangxi Boya Bio-Pharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
GREEN CROSS
Shanghai XinXing Medical
Taibang Biologic
Octapharma
Fibrinogen Concentrates Product Segment Include:
Human Fibrinogen
Animal Fibrinogen
Fibrinogen Concentrates Product Application Include:
Congenital Fibrinogen Deficiency
Surgical Procedures
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Fibrinogen Concentrates Industry PESTEL Analysis
Chapter 3: Global Fibrinogen Concentrates Industry Porter's Five Forces Analysis
Chapter 4: Global Fibrinogen Concentrates Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Fibrinogen Concentrates Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Fibrinogen Concentrates Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Fibrinogen Concentrates Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Fibrinogen Concentrates market size will reach 1,305.25 Million USD in 2025 and is projected to reach 2,943.70 Million USD by 2032, with a CAGR of 12.32% (2025-2032). Notably, the China Fibrinogen Concentrates market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Fibrinogen concentrates are pharmaceutical products used in medicine to treat individuals with bleeding disorders, particularly those with low levels of fibrinogen in their blood. These concentrates are derived from human plasma or produced using recombinant technology, and they contain concentrated and purified forms of fibrinogen. They are administered intravenously to quickly replenish fibrinogen levels, helping to promote blood clot formation and control bleeding in patients with conditions such as congenital fibrinogen deficiency, acquired hypofibrinogenemia, or as part of massive transfusion protocols in surgical and trauma settings. Fibrinogen concentrates are valuable therapeutic tools in managing bleeding disorders and can be more targeted and efficient than using traditional blood products like fresh frozen plasma.
The major global manufacturers of Fibrinogen Concentrates include CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, GREEN CROSS, Shanghai XinXing Medical, Taibang Biologic, Octapharma, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Fibrinogen Concentrates. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Fibrinogen Concentrates market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Fibrinogen Concentrates market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Fibrinogen Concentrates industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Fibrinogen Concentrates Include:
CSL Behring
LFB Group
Shanghai RAAS Blood Products
Jiangxi Boya Bio-Pharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
GREEN CROSS
Shanghai XinXing Medical
Taibang Biologic
Octapharma
Fibrinogen Concentrates Product Segment Include:
Human Fibrinogen
Animal Fibrinogen
Fibrinogen Concentrates Product Application Include:
Congenital Fibrinogen Deficiency
Surgical Procedures
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Fibrinogen Concentrates Industry PESTEL Analysis
Chapter 3: Global Fibrinogen Concentrates Industry Porter's Five Forces Analysis
Chapter 4: Global Fibrinogen Concentrates Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Fibrinogen Concentrates Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Fibrinogen Concentrates Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Fibrinogen Concentrates Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Fibrinogen Concentrates Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Fibrinogen Concentrates Product by Type
- 1.2.1 Human Fibrinogen
- 1.2.2 Animal Fibrinogen
- 1.3 Fibrinogen Concentrates Product by Application
- 1.3.1 Congenital Fibrinogen Deficiency
- 1.3.2 Surgical Procedures
- 1.3.3 Others
- 1.4 Global Fibrinogen Concentrates Market Revenue and Sales Analysis
- 1.4.1 Global Fibrinogen Concentrates Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Fibrinogen Concentrates Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Fibrinogen Concentrates Market Sales Price Trend Analysis (2020-2032)
- 1.5 Fibrinogen Concentrates Market Development Status and Trends
- 1.5.1 Fibrinogen Concentrates Industry Development Status Analysis
- 1.5.2 Fibrinogen Concentrates Industry Development Trends Analysis
- 2 Fibrinogen Concentrates Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Fibrinogen Concentrates Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Fibrinogen Concentrates Market Analysis by Country
- 4.1 Global Fibrinogen Concentrates Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Fibrinogen Concentrates Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Fibrinogen Concentrates Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Fibrinogen Concentrates Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Fibrinogen Concentrates Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Fibrinogen Concentrates Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Fibrinogen Concentrates Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Fibrinogen Concentrates Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Fibrinogen Concentrates Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Fibrinogen Concentrates Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Fibrinogen Concentrates Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Fibrinogen Concentrates Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Fibrinogen Concentrates Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Fibrinogen Concentrates Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Fibrinogen Concentrates Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Fibrinogen Concentrates Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Fibrinogen Concentrates Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Fibrinogen Concentrates Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Fibrinogen Concentrates Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Fibrinogen Concentrates Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Fibrinogen Concentrates Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Fibrinogen Concentrates Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Fibrinogen Concentrates Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Fibrinogen Concentrates Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Fibrinogen Concentrates Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Fibrinogen Concentrates Average Sales Price by Manufacturers (2021-2025)
- 5.2 Fibrinogen Concentrates Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Fibrinogen Concentrates Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Fibrinogen Concentrates Market Analysis by Type
- 6.1 Global Fibrinogen Concentrates Market Revenue Analysis by Type
- 6.1.1 Global Fibrinogen Concentrates Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Fibrinogen Concentrates Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Fibrinogen Concentrates Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Fibrinogen Concentrates Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 CSL Behring
- 7.1.1 CSL Behring Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 CSL Behring Fibrinogen Concentrates Product Portfolio
- 7.1.3 CSL Behring Fibrinogen Concentrates Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 LFB Group
- 7.2.1 LFB Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 LFB Group Fibrinogen Concentrates Product Portfolio
- 7.2.3 LFB Group Fibrinogen Concentrates Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 Shanghai RAAS Blood Products
- 7.3.1 Shanghai RAAS Blood Products Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Shanghai RAAS Blood Products Fibrinogen Concentrates Product Portfolio
- 7.3.3 Shanghai RAAS Blood Products Fibrinogen Concentrates Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Jiangxi Boya Bio-Pharmaceutical
- 7.4.1 Jiangxi Boya Bio-Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Jiangxi Boya Bio-Pharmaceutical Fibrinogen Concentrates Product Portfolio
- 7.4.3 Jiangxi Boya Bio-Pharmaceutical Fibrinogen Concentrates Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Hualan Biological Engineering
- 7.5.1 Hualan Biological Engineering Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Hualan Biological Engineering Fibrinogen Concentrates Product Portfolio
- 7.5.3 Hualan Biological Engineering Fibrinogen Concentrates Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 Harbin Pacific Biopharmaceutical
- 7.6.1 Harbin Pacific Biopharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Harbin Pacific Biopharmaceutical Fibrinogen Concentrates Product Portfolio
- 7.6.3 Harbin Pacific Biopharmaceutical Fibrinogen Concentrates Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 GREEN CROSS
- 7.7.1 GREEN CROSS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 GREEN CROSS Fibrinogen Concentrates Product Portfolio
- 7.7.3 GREEN CROSS Fibrinogen Concentrates Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.8 Shanghai XinXing Medical
- 7.8.1 Shanghai XinXing Medical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Shanghai XinXing Medical Fibrinogen Concentrates Product Portfolio
- 7.8.3 Shanghai XinXing Medical Fibrinogen Concentrates Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.9 Taibang Biologic
- 7.9.1 Taibang Biologic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Taibang Biologic Fibrinogen Concentrates Product Portfolio
- 7.9.3 Taibang Biologic Fibrinogen Concentrates Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.10 Octapharma
- 7.10.1 Octapharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Octapharma Fibrinogen Concentrates Product Portfolio
- 7.10.3 Octapharma Fibrinogen Concentrates Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Fibrinogen Concentrates Industry Chain Analysis
- 8.2 Fibrinogen Concentrates Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Fibrinogen Concentrates Product Downstream Application Analysis
- 8.3.1 Global Fibrinogen Concentrates Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Fibrinogen Concentrates Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Fibrinogen Concentrates Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Fibrinogen Concentrates Typical Downstream Customers
- 8.5 Fibrinogen Concentrates Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
